AGP Picks
View all

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on September 17, 2026

As Lithium Battery Use Expands, HazMat Safety Consulting Expert to Address Regulatory Gaps at CHEMTREC Int’l Summit
Texas Tech University Health Sciences Center awarded $24.5 million five-year grant from National Institutes of Health
Tenora Laser Studio Opens in San Antonio with Advanced Candela Laser Technology for Tattoo and Hair Removal
Shriners Children's Announces Landmark Deals with Dallas Cowboys, Scripps Sports for East-West Bowl
C3HIE Achieves HITRUST e1 Certification, Demonstrating Commitment to Cybersecurity and Information Protection
Horton Automatics Launches EasyLearn Online Training Program for Commercial Door Professionals
Pulmonary Fibrosis Awareness Month Underway, Events, Education and Advocacy Efforts Announced
BioTech Social Announces Advisory Board to Advance Financial Innovation for Life Science Companies
Treace Announces Results of Three Clinical Studies Including the Milestone 5-Year ALIGN3D® Study Demonstrating Sustained, Positive Outcomes of the Lapiplasty® Procedure
Onco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)
NOMAD POWER SOLUTIONS FILES EXPANDED BUSINESS AND FINANCIAL DISCLOSURE FOLLOWING COMPLETION OF MERGER
Phase 3 Pediatric EMPAVELI Data Published in Clinical Journal of the American Society of Nephrology Show Reduction in Proteinuria and Stabilized Kidney Function in Adolescents with C3G or Primary IC-MPGN
Beta Bionics Announces Closing of $172.5 Million Public Offering of Common Stock
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vireo Growth Inc. Announces Issuance of Shares in Connection with Altmore Settlement
argenx announces results of Extraordinary General Meeting of Shareholders and appointment of Thomas M. Brakel and Khurem Farooq as Non-Executive Directors
Xenon Announces Azetukalner NDA Submission to FDA for Focal Seizures and Provides Update on Psychiatry Clinical Program
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MAPS Attends Historic FDA Hearing on Psychedelics
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Healthcare Wire Texas

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.